Article
A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma
2026-01-20
Abstract excerpt
<h4>ABSTRACT</h4> Large B-cell lymphomas (LBCLs) are a clinically and molecularly diverse group of malignancies with a rapidly evolving therapeutic landscape that has introduced new areas of clinical need such as post-CD19 chimeric antigen receptor T (CART19) progression. Patient derived xenograft (PDX) models are an important tool for mechanistic studies and preclinical evaluation of new therapies and can be gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 065bdaac-f28c-5953-b36d-10879931f563
- DOI
- 10.64898/2026.01.19.700406
